Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

AgeUp to 18

SponsorTanta University

About this trial

The aim of this study is to evaluate the outcome of botulinum toxin A (BTX-A) injection for management of children with :

A-Dysfunctional voiding who are not responding to traditional treatment. B-Refractory nocturnal enuresis.

Children < 18 years.

Both sexes.

Patients with refractory nocturnal enuresis or dysfunctional voiding who are not responding to the traditional treatment.

Bleeding disorders.

Neuromusclar disorder(e.g.,Myasthenia gravis).

Patients who are not fit for anaesthesia.

Active urinary tract infection (UTI).

64 Participants

are divided into 1 treatment group

Tanta University

Lead sponsor